Peter Kies is CFO of INOVIO PHARMACEUTICALS, INC.. Currently has a direct ownership of 24,367 shares of INO, which is worth approximately $135,236. The most recent transaction as insider was on Jan 15, 2021, when has been sold 30,000 shares (Common Stock) at a price of $4.56 per share, resulting in proceeds of $136,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.4K
0% 3M change
89.72% 12M change
Total Value Held $135,236

PETER KIES Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 15 2021
BUY
Exercise of conversion of derivative security
$136,800 $4.56 p/Share
30,000 Added 16.73%
149,290 Common Stock
Dec 15 2020
SELL
Open market or private sale
$213,800 $10.69 p/Share
20,000 Reduced 14.36%
119,290 Common Stock
Dec 15 2020
BUY
Exercise of conversion of derivative security
$45,600 $2.28 p/Share
20,000 Added 12.56%
139,290 Common Stock
PK

Peter Kies

CFO
San Diego, CA

Track Institutional and Insider Activities on INO

Follow INOVIO PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INO shares.

Notify only if

Insider Trading

Get notified when an Inovio Pharmaceuticals, Inc. insider buys or sells INO shares.

Notify only if

News

Receive news related to INOVIO PHARMACEUTICALS, INC.

Track Activities on INO